99 related articles for article (PubMed ID: 10509320)
1. Carcinoma of the esophagus. Part 1: Primary therapy.
Minsky BD
Oncology (Williston Park); 1999 Sep; 13(9):1225-32, 1235-6. PubMed ID: 10509320
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma of the esophagus. Part 2: Adjuvant therapy.
Minsky BD
Oncology (Williston Park); 1999 Oct; 13(10):1415-27; discussion 1427 passim. PubMed ID: 10549567
[TBL] [Abstract][Full Text] [Related]
3. Optimal treatment for localized esophageal cancer still uncertain.
Lord RV
Am J Gastroenterol; 2000 Jan; 95(1):305-7. PubMed ID: 10638607
[TBL] [Abstract][Full Text] [Related]
4. Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis.
Hong JC; Murphy JD; Wang SJ; Koong AC; Chang DT
Ann Surg Oncol; 2013 Nov; 20(12):3999-4007. PubMed ID: 23800897
[TBL] [Abstract][Full Text] [Related]
5. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
[TBL] [Abstract][Full Text] [Related]
6. Preoperative chemoradiation therapy does not improve early survival after esophagectomy for patients with clinical stage III adenocarcinoma of the esophagus.
Donington JS; Miller DL; Allen MS; Deschamps C; Nichols FC; Pairolero PC
Ann Thorac Surg; 2004 Apr; 77(4):1193-8; discussion 1198-9. PubMed ID: 15063233
[TBL] [Abstract][Full Text] [Related]
7. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J
Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
[TBL] [Abstract][Full Text] [Related]
8. [Value of radiotherapy and chemotherapy in treatment of operable cancers of the esophagus].
Msika S; Hay JM
J Chir (Paris); 2002 Feb; 139(1):17-24. PubMed ID: 12071024
[TBL] [Abstract][Full Text] [Related]
9. Treatment of esophageal cancer based on histology: a surveillance epidemiology and end results analysis.
Chang DT; Chapman C; Shen J; Su Z; Koong AC
Am J Clin Oncol; 2009 Aug; 32(4):405-10. PubMed ID: 19415029
[TBL] [Abstract][Full Text] [Related]
10. Phase I/II trial of preoperative oxaliplatin, docetaxel, and capecitabine with concurrent radiation therapy in localized carcinoma of the esophagus or gastroesophageal junction.
Spigel DR; Greco FA; Meluch AA; Lane CM; Farley C; Gray JR; Clark BL; Burris HA; Hainsworth JD
J Clin Oncol; 2010 May; 28(13):2213-9. PubMed ID: 20351330
[TBL] [Abstract][Full Text] [Related]
11. Esophageal carcinoma: modest benefits from combined modality therapy.
Hancock SL; Goffinet DR; Carlson RW; Mark JB
Radiology; 1987 Sep; 164(3):603-6. PubMed ID: 3112863
[TBL] [Abstract][Full Text] [Related]
12. Treating esophageal cancer with a combination of chemotherapy, radiation, and excision.
Girvin GW; Matsumoto GH; Bates DM; Garcia JM; Clyde JC; Lin PH
Am J Surg; 1995 May; 169(5):557-9. PubMed ID: 7747839
[TBL] [Abstract][Full Text] [Related]
13. Preoperative chemotherapy and radiotherapy for esophageal carcinoma.
Naunheim KS; Petruska P; Roy TS; Andrus CH; Johnson FE; Schlueter JM; Baue AE
J Thorac Cardiovasc Surg; 1992 May; 103(5):887-93; discussion 893-5. PubMed ID: 1569771
[TBL] [Abstract][Full Text] [Related]
14. Resectable esophageal carcinoma: local control with neoadjuvant chemotherapy and radiation therapy.
Chidel MA; Rice TW; Adelstein DJ; Kupelian PA; Suh JH; Becker M
Radiology; 1999 Oct; 213(1):67-72. PubMed ID: 10540642
[TBL] [Abstract][Full Text] [Related]
15. [Current diagnosis and therapy of esophageal carcinoma].
Mühr-Wilkenshoff F; Stahl M; Faiss S; Zeitz M; Scherübl H
Z Gastroenterol; 2004 Jul; 42(7):615-21. PubMed ID: 15248111
[TBL] [Abstract][Full Text] [Related]
16. Survival of patients with carcinoma of the esophagus treated with combined-modality therapy.
Wolfe WG; Vaughn AL; Seigler HF; Hathorn JW; Leopold KA; Duhaylongsod FG
J Thorac Cardiovasc Surg; 1993 Apr; 105(4):749-55; discussion 755-6. PubMed ID: 8469009
[TBL] [Abstract][Full Text] [Related]
17. Role of neoadjuvant therapy for esophageal adenocarcinoma.
Ku GY; Ilson DH
Surg Oncol Clin N Am; 2009 Jul; 18(3):533-46. PubMed ID: 19500742
[TBL] [Abstract][Full Text] [Related]
18. Multimodality treatment in the management of esophageal cancer: neoadjuvant chemoradiotherapy followed by transhiatal esophagectomy.
Irwin JF; Waterfield W; Poussin-Rosillo H; Sardi A
Md Med J; 1997 Oct; 46(9):471-76. PubMed ID: 9327648
[TBL] [Abstract][Full Text] [Related]
19. Preoperative chemoradiotherapy for carcinoma of the esophagus and gastroesophageal junction.
Posner MC; Gooding WE; Landreneau RJ; Rosenstein MM; Clarke MR; Peterson MS; Lembersky BC
Cancer J Sci Am; 1998; 4(4):237-46. PubMed ID: 9689982
[TBL] [Abstract][Full Text] [Related]
20. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution.
Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E
Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]